{"schema_version":"secwatch.filing_event.v1","accession":"0001625297-25-000042","form_type":"8-K","ticker":"INDV","cik":"0001625297","company_name":"Indivior Pharmaceuticals, Inc.","filed_at":"2025-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.105750+00:00","generated_at":"2026-05-18T22:39:39.090239+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Indivior appoints Tony Kingsley to board; directors adopt equity purchase plan","bullets":["Appointed Tony Kingsley as independent non-executive director effective July 1, 2025.","Kingsley appointed per Oaktree relationship agreement; former CEO of Scholar Rock and Stablix.","Five US non-executive directors entered JP Morgan purchase plan; company funds ~70% of after-tax retainer into shares.","UK director Juliet Thompson bought 1,925 shares on June 11; company to reimburse over next year."],"urls":{"canonical":"https://secwatch.observer/filing/0001625297-25-000042","json":"https://secwatch.observer/filing/0001625297-25-000042.json","markdown":"https://secwatch.observer/filing/0001625297-25-000042.md","text":"https://secwatch.observer/filing/0001625297-25-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625297/000162529725000042/0001625297-25-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625297/000162529725000042/indv-20250620.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T22:39:39.090239+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}